Global Genomic Medicine Collaborative
EIN: 813079744 · Durham, NC · NTEE: E05
Is Global Genomic Medicine Collaborative Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Global Genomic Medicine Collaborative
Global Genomic Medicine Collaborative (EIN: 813079744) is a nonprofit organization based in Durham, NC, classified under NTEE code E05. The organization reported total revenue of $667K and total assets of $286K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Global Genomic Medicine Collaborative's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Global Genomic Medicine Collaborative is a small nonprofit that has been operating for 8 years, with 7 years of IRS 990 filings on record (2017–2023). Revenue has grown at a compound annual rate of 0.5%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $227K |
| Total Expenses | $1.2M |
| Surplus / Deficit | $-956,726 |
| Total Assets | $280K |
| Total Liabilities | $3K |
| Net Assets | $277K |
| Operating Margin | -422.3% |
| Debt-to-Asset Ratio | 1.1% |
| Months of Reserves | 2.8 months |
Financial Health Grade: C
In 2023, Global Genomic Medicine Collaborative reported a deficit of $957K with expenses exceeding revenue, holds 2.8 months of operating reserves (limited), has a debt-to-asset ratio of 1.1% (very low leverage).
Financial Trends
Over 7 years of filings (2017–2023), Global Genomic Medicine Collaborative's revenue has grown at a compound annual growth rate (CAGR) of 0.5%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -76.2% | +9.3% | -77.3% |
| 2022 | -43.6% | +13.3% | -9.6% |
| 2021 | +83.9% | +36.9% | +115.6% |
| 2020 | +178.9% | +71.7% | +50.2% |
| 2019 | -46.0% | +18.5% | -14.0% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 2018 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Global Genomic Medicine Collaborative has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Global Genomic Medicine Collaborative with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $957K, with expenses exceeding revenue.
- Debt-to-asset ratio: 1.1%.
Frequently Asked Questions about Global Genomic Medicine Collaborative
Is Global Genomic Medicine Collaborative a legitimate charity?
Based on AI analysis of IRS 990 filings, Global Genomic Medicine Collaborative (EIN: 813079744) insufficient data. 0 red flags identified, 0 strengths noted.
How does Global Genomic Medicine Collaborative spend its money?
Detailed spending breakdown data is not yet available for Global Genomic Medicine Collaborative. Check back for updated IRS 990 analysis.
Are donations to Global Genomic Medicine Collaborative tax-deductible?
Global Genomic Medicine Collaborative is registered as a tax-exempt nonprofit (EIN: 813079744). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Filing History
IRS 990 filing history for Global Genomic Medicine Collaborative showing financial trends over 7 years of public records:
Over 7 years of IRS 990 filings (2017–2023), Global Genomic Medicine Collaborative's revenue has grown by 3%, moving from $220K to $227K. Total assets increased by 25.1% over the same period, from $224K to $280K. Total functional expenses rose by 993.9%, from $108K to $1.2M. In its most recent filing year (2023), Global Genomic Medicine Collaborative reported a deficit of $957K, with expenses exceeding revenue. The organization holds $3K in liabilities against $280K in assets (debt-to-asset ratio: 1.1%), resulting in net assets of $277K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $227K | $1.2M | $280K | $3K | — | — |
| 2022 | $952K | $1.1M | $1.2M | $875 | — | View 990 |
| 2021 | $1.7M | $955K | $1.4M | $2K | — | View 990 |
| 2020 | $918K | $698K | $633K | $1K | — | — |
| 2019 | $329K | $406K | $421K | $9K | — | View 990 |
| 2018 | $609K | $343K | $490K | $597 | — | View 990 |
| 2017 | $220K | $108K | $224K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $227K, expenses of $1.2M, and assets of $280K (revenue -76.2% year-over-year).
- 2022: Revenue of $952K, expenses of $1.1M, and assets of $1.2M (revenue -43.6% year-over-year).
- 2021: Revenue of $1.7M, expenses of $955K, and assets of $1.4M (revenue +83.9% year-over-year).
- 2020: Revenue of $918K, expenses of $698K, and assets of $633K (revenue +178.9% year-over-year).
- 2019: Revenue of $329K, expenses of $406K, and assets of $421K (revenue -46.0% year-over-year).
- 2018: Revenue of $609K, expenses of $343K, and assets of $490K (revenue +176.7% year-over-year).
- 2017: Revenue of $220K, expenses of $108K, and assets of $224K.
Data Sources and Methodology
This transparency report for Global Genomic Medicine Collaborative is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.